Correlation Between NYSE Composite and BriaCell Therapeutics
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and BriaCell Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and BriaCell Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and BriaCell Therapeutics Corp, you can compare the effects of market volatilities on NYSE Composite and BriaCell Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of BriaCell Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and BriaCell Therapeutics.
Diversification Opportunities for NYSE Composite and BriaCell Therapeutics
0.61 | Correlation Coefficient |
Poor diversification
The 3 months correlation between NYSE and BriaCell is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and BriaCell Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BriaCell Therapeutics and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with BriaCell Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BriaCell Therapeutics has no effect on the direction of NYSE Composite i.e., NYSE Composite and BriaCell Therapeutics go up and down completely randomly.
Pair Corralation between NYSE Composite and BriaCell Therapeutics
Assuming the 90 days trading horizon NYSE Composite is expected to generate 35.86 times less return on investment than BriaCell Therapeutics. But when comparing it to its historical volatility, NYSE Composite is 20.33 times less risky than BriaCell Therapeutics. It trades about 0.12 of its potential returns per unit of risk. BriaCell Therapeutics Corp is currently generating about 0.2 of returns per unit of risk over similar time horizon. If you would invest 19.00 in BriaCell Therapeutics Corp on September 13, 2024 and sell it today you would earn a total of 35.00 from holding BriaCell Therapeutics Corp or generate 184.21% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 98.41% |
Values | Daily Returns |
NYSE Composite vs. BriaCell Therapeutics Corp
Performance |
Timeline |
NYSE Composite and BriaCell Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
BriaCell Therapeutics Corp
Pair trading matchups for BriaCell Therapeutics
Pair Trading with NYSE Composite and BriaCell Therapeutics
The main advantage of trading using opposite NYSE Composite and BriaCell Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, BriaCell Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BriaCell Therapeutics will offset losses from the drop in BriaCell Therapeutics' long position.NYSE Composite vs. Boston Beer | NYSE Composite vs. Freedom Bank of | NYSE Composite vs. KeyCorp | NYSE Composite vs. LithiumBank Resources Corp |
BriaCell Therapeutics vs. Briacell Therapeutics Corp | BriaCell Therapeutics vs. GeoVax Labs | BriaCell Therapeutics vs. immatics biotechnologies GmbH | BriaCell Therapeutics vs. CannBioRx Life Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Complementary Tools
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |